Biotech

All Articles

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Therapeutics was made an impression on enough with Harbour BioMed's bispecific immune syst...

A more detailed look at Intense Biotech's Intense 15

.In this week's episode of "The Best Line," we're diving into Ferocious Biotech's yearly Ferocious 1...

Lilly deals with phase 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration commemorating the commendation of ...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of substantial management hirings, firings a...

Lykos will talk to FDA to reassess its choice following denial of MDMA therapy for trauma

.Complying with a poor presenting for Lykos Therapeutics' MDMA prospect for trauma at a latest FDA a...

AN 2 fifty percents head count, stops period 3 trial after data disappoint

.AN2 Therapeutics is actually re-thinking its business in feedback to poor midphase records, promisi...

Merck pays for $700M for bispecific, spying autoimmune opening as well as possibility to test Amgen in cancer cells

.Merck &amp Co. is paying out $700 million upfront to challenge Amgen in a blood stream cancer marke...

Gilead pays for J&ampJ $320M to exit licensing package for seladelpar

.Along With Gilead Sciences on the verge of an FDA selection for its liver disease medication selade...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks can find the companies putting together tents at basecamp respo...

Entero laying off personnel, moving out of office as well as stopping R&ampD

.Bed mattress Liquidators has actually transformed Entero Therapies white colored as a piece. The co...